With patent clocks ticking it would make sense to leverage it by commercialise what we can and then use those funds to pursue trials, right? Also with separate FTD’s in place for CLARIFY & AMPLIFY they don’t have to bundle the submissions to have FDA review them together as the approvals likely would be separate by indication.
CU6 Price at posting:
$2.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)